 comparison induct mainten therapi acut nonlymphocyt leukemia childhood result pediatr oncolog group studi fifty-six children acut nonlymphocyt leukemia anll pediatr oncolog group pog phase iii trial induct continu chemotherapi induct therapi vincristin cytarabin dexamethason vadx daunorubicin cytarabin thioguanin dat complet remiss CR rate dat superior postremiss therapi standard two-cycl therapi intens four-cycl regimen year overal differ outcom patient continu regimen overal complet continu remiss rate ccr induction/continu therapi combin year SE year year analysi clinic laboratori paramet differ induct respons dat induct eventu disease-fre surviv subgroup patient four-cycl continu therapi patient french-american-british fab ccr patient year diagnosi